The prevalence of HPV16/18 in cervical cancer has been reported to decline with age in
some papers. However, whether this decline in proportion of cancers positive for HPV16/18 …

PURPOSE We conducted an integrated population-based analysis of histologic subtype–
specific cervical cancer incidence, survival, and incidence-based mortality by race and …

Background: The impact of human papillomavirus (HPV) vaccination has been observed in
the United States through declining cervical precancer incidence in young women. To …

Background The presence of human papillomavirus (HPV) DNA in oropharyngeal
squamous cell cancer (OPSCC) tissue appears to be a strong predictor of improved …

HPV35 has been found in only∼ 2% of invasive cervical cancers (ICC) worldwide but up to
10% in Sub‐Saharan Africa, warranting further investigation and consideration of impact on …

We conducted a study to determine prevalence of HPV types in oropharyngeal cancers in
the United States and establish a prevaccine baseline for monitoring the impact of …

Declines in cervical intraepithelial neoplasia grades 2 to 3 and adenocarcinoma in situ
(CIN2+) observed among young women suggest impact from human papillomavirus (HPV) …

BACKGROUND: Vaccination against human papillomavirus (HPV) types 16 and 18 is
recommended for girls aged 11 or 12 years with catch-up vaccination through age 26 in the …

Background Racial and ethnic variations in attribution of cervical precancer and cancer to
human papillomavirus (HPV) types may result in different HPV vaccine protection, screening …

OBJECTIVE: To describe the human papillomavirus (HPV) genotype distribution in invasive
vaginal cancers diagnosed before the introduction of the HPV vaccine and evaluate if …